From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Many pharmaceutical manufacturers struggle to evaluate and implement a series of pricing and contracting decisions leading up to their first commercial launch. IntegriChain has market-tested blueprints for commercial, government/compliance, and gross-to-net launches.
Our flexible deal analytics framework and methodology around payer pre-deal analysis can assist pharma manufacturers in evaluating pricing and contracting strategies for pharmacy benefit managers (PBMs) and other payers in the lead up to launch, as outlined below.
To address the challenges in pharma launch strategies, IntegriChain’s Commercial Roadmap to Launch provides a series of analytical and operational services including:
Pre-commercial pharma manufacturers need to prepare for participation in key government programs to ensure they have access to these critical channels for their upcoming product launch, and are ready to comply with all price reporting requirements.
To address these challenges, IntegriChain’s Government & Compliance Roadmap to Launch includes the following services:
Finance leaders within pre-commercial pharma manufacturers often worry about their ability to close their financial statements “Month One” and/or the first quarter after launch, due to lack of resources or time to define and build a trusted, efficient, and audit-ready gross-to-net (GTN) process.
To address these challenges, IntegriChain’s Gross-to-Net Roadmap to Launch includes the following services:
Let’s Build a Pharma Launch Plan
A top 10 pharmaceutical manufacturer was preparing to launch a complex oncology combination regimen with two novel agents but was faced with several unique commercial challenges.
Read the Case Study
Learn more about IntegriChain’s comprehensive Commercial Roadmap to Launch Program for both emerging and established companies preparing for product launch
Download Now
